Skip to content

Phenytoin and Multidose Activated Charcoal

Prospective Randomized Study of Multidose Activated Charcoal in Supratherapeutic Phenytoin Serum Levels

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00823264
Enrollment
17
Registered
2009-01-15
Start date
2008-08-31
Completion date
2012-01-31
Last updated
2014-09-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Phenytoin Toxicity

Keywords

Anticonvulsants, Toxicology, multidose charcoal, phenytoin

Brief summary

Phenytoin is a medicine used to treat seizures. If too much is taken, patients have ill effects including sleepiness, unsteady gait, and eye problems. The amount of drug in their system can be measured in their blood. Charcoal is a medicine that can absorb phenytoin. We want to see if giving multiple doses of charcoal will quicken the removal of phenytoin from the blood. This is theorized to occur as charcoal absorbs phenytoin from across the intestines and then is secreted in the stool. Patients will be selected to receive either charcoal in multiple doses or no charcoal and their serum levels will be drawn repeatedly to follow their level. The different groups will then be compared to see if multidose charcoal does indeed increase the elimination of phenytoin from the body.

Detailed description

See above

Interventions

50 grams by mouth every 4 hours until serum phenytoin level is less than 25.

Sponsors

Emory University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Phenytoin level \> 30 mg/L

Exclusion criteria

* Age \< 18 * Known allergy to Activated Charcoal * Pregnant * Inability to take PO drugs * Non English speaking * Inability to give consent * Any prisoners

Design outcomes

Primary

MeasureTime frameDescription
Time of Elimination of Phenytoin in Patients With Elevated Phenytoin LevelsSerum phenytoin levels were obtained every 6 hours for 24 hours then once every 24 hoursWe enrolled patients with elevated phenytoin levels into the study with greater than 30 ug/cc. The treatment arm received multiple doses of activated charcoal and the control arm received no activated charcoal. We obtained serum phenytoin levels every 6 hours for 24 hours then once every 24 hours. The time to reach a subtoxic level was determined in each arm by looking at serum phenytoin levels and documenting when it was below 25 ug/cc.

Countries

United States

Participant flow

Participants by arm

ArmCount
Control
Will not receive activated charcoal. Serum levels will be followed.
8
Multiple Doses of Activated Charcoal
Will receive 50 grams of activated charcoal by mouth every 4 hours until phenytoin levels are \< 25 ug/cc.
7
Total15

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyProtocol Violation20

Baseline characteristics

CharacteristicControlMultiple Doses of Activated CharcoalTotal
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
1 Participants0 Participants1 Participants
Age, Categorical
Between 18 and 65 years
7 Participants7 Participants14 Participants
Region of Enrollment
United States
8 participants7 participants15 participants
Sex: Female, Male
Female
0 Participants0 Participants0 Participants
Sex: Female, Male
Male
8 Participants7 Participants15 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 70 / 8
serious
Total, serious adverse events
0 / 70 / 8

Outcome results

Primary

Time of Elimination of Phenytoin in Patients With Elevated Phenytoin Levels

We enrolled patients with elevated phenytoin levels into the study with greater than 30 ug/cc. The treatment arm received multiple doses of activated charcoal and the control arm received no activated charcoal. We obtained serum phenytoin levels every 6 hours for 24 hours then once every 24 hours. The time to reach a subtoxic level was determined in each arm by looking at serum phenytoin levels and documenting when it was below 25 ug/cc.

Time frame: Serum phenytoin levels were obtained every 6 hours for 24 hours then once every 24 hours

ArmMeasureValue (MEDIAN)
ControlTime of Elimination of Phenytoin in Patients With Elevated Phenytoin Levels41.1 hours
Multiple Doses of Activated CharcoalTime of Elimination of Phenytoin in Patients With Elevated Phenytoin Levels19.3 hours
p-value: 0.049Wilcoxon (Mann-Whitney)

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026